$2.37
4.87% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US09060U5074
Symbol
BCDA
Sector
Industry

BioCardia Inc. Target price 2024 - Analyst rating & recommendation

BioCardia Inc. Classifications & Recommendation:

Buy
100%

BioCardia Inc. Price Target

Target Price $25.00
Price $2.37
Potential
Number of Estimates 1
1 Analyst has issued a BioCardia Inc. price target 2025. The average BioCardia Inc. target price is $25.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend BioCardia Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioCardia Inc. stock has an average upside potential 2025 of . Most analysts recommend the BioCardia Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.48 0.10
64.44% 79.17%
EBITDA Margin -2,339.58% -9,700.00%
174.17% 314.60%
Net Margin -7,712.25% -21,696.00%
3,337.97% 181.32%

1 Analyst has issued a sales forecast BioCardia Inc. 2024 . The average BioCardia Inc. sales estimate is

$100k
Unlock
. This is
42.86% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$100k 42.86%
Unlock
, the lowest is
$100k 42.86%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $480k 64.44%
2024
$100k 79.17%
Unlock
2025
$100k 0.00%
Unlock
2026
$100k 0.00%
Unlock
2027
$100k 0.00%
Unlock
2028
$8.4m 8,300.00%
Unlock

1 Analyst has issued an EBITDA forecast BioCardia Inc. 2024 . The average BioCardia Inc. EBITDA estimate is

$-9.7m
Unlock
. This is
32.15% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-9.7m 32.15%
Unlock
, the lowest is
$-9.7m 32.15%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-11.2m 2.52%
2024
$-9.7m 13.62%
Unlock
2025
$-11.0m 13.40%
Unlock
2026
$-13.1m 19.09%
Unlock
2027
$-16.1m 22.90%
Unlock
2028
$-14.2m 11.80%
Unlock

EBITDA Margin

2023 -2,339.58% 174.17%
2024
-9,700.00% 314.60%
Unlock
2025
-11,000.00% 13.40%
Unlock
2026
-13,100.00% 19.09%
Unlock
2027
-16,100.00% 22.90%
Unlock
2028
-169.05% 98.95%
Unlock

The average BioCardia Inc. net profit estimate is

$-21.7m
Unlock
. This is
15.41% lower
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-37.0m 1,122.39%
2024
$-21.7m 41.38%
Unlock
2025
$-31.2m 43.73%
Unlock

Net Margin

2023 -7,712.25% 3,337.97%
2024
-21,696.00% 181.32%
Unlock
2025
-31,188.00% 43.75%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -8.19 -4.80
1,122.39% 41.39%
P/E negative
EV/Sales 69.80

The average BioCardia Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-4.80
Unlock
. This is
15.38% lower
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-8.19 1,122.39%
2024
$-4.80 41.39%
Unlock
2025
$-6.90 43.75%
Unlock

P/E ratio

Current -0.57 49.56%
2024
-0.49 14.04%
Unlock
2025
-0.34 30.61%
Unlock

Based on analysts' sales estimates for 2024, the BioCardia Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

69.80
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
108.60
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 99.71 281.74%
2024
69.80 30.00%
Unlock
2025
69.80 0.00%
Unlock
2026
69.80 0.00%
Unlock
2027
69.80 0.00%
Unlock
2028
0.83 98.81%
Unlock

P/S ratio

Current 155.14 476.85%
2024
108.60 30.00%
Unlock
2025
108.60 0.00%
Unlock
2026
108.60 0.00%
Unlock
2027
108.60 0.00%
Unlock
2028
1.29 98.81%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today